학술논문

Pelvic Floor Rehabilitation After Rectal Cancer Surgery: A Multicenter Randomized Clinical Trial (FORCE Trial)
Document Type
Academic Journal
Author
van der Heijden, J. A. G.Kalkdijk-Dijkstra, A. J.Pierie, J. P. E. N.van Westreenen, H. L.Broens, P. M. A.Klarenbeek, B. R.de Wilt, JHWStommel, MWJBremers, AJARosman, Cde Reuver, PRBouwense, SAWvan der Kolk, BMGarms, LMMeerten-van den Belt, KOlde Hartman-Hofste, MRMPeters, JWMOlsder, LHuizing, ITrzpis, MFurnee, EJBHavenga, KHemmer, PHJvan Etten, BKoop, Avan der Heide, LKamphuis, DKoopal, SAHoff, CEker, HJunte, HHMSchoenaker, IJHQuaedackers, SBos, MJGardien, Hvan Sprundel, TCde Vries, PDAshruf, JFGeurts, LNielen, IPfeil, Jvan Ark, MPolle, SWHansson, BPolat, Fde Vries, Hten Berge-Groen, ETalsma, AKBosker, RVeurink, EPapa, MMaaskant-Braat, AJGvan den Broek, FJCLeclercq, WKGSlooter, GDCaers, FBoeijen, Mvan den Broek, Rvan Schaik, KWasowicz-Kemps, DKLangenhoff, BSvan den Bogaard, MJvan der Sluis, JArisz, DBruinsma, SHess, DAMulder, EJWiering, BKok, SWoltering, JRaap-van Sleuwen, BSchoonderwoerd, LHendriks, Dvan den Elzen, Nvan de Laak, IValk, Mvan der Meij, Wvan Wely, BJvan Hoogstraten, MJvan der Sluis, MPaulusma, IMollers, MJWLooijen, Rvan der Mijle, HCJPereboom, ITATijink-Callenbach, PMCSchasfoort, RAvan der Hagen, SJvan de Meer, WLubberink, Mvan Haskera, MWit, FJeeninga, Mten Hoeve, RSlootmans, FCWInberg, Bde Nes, LToonen, DWilmsen, MABuyne, OFerenschild, Fde Vries, M.Adamse, CHettema-Beets, BLGoudswaard, MKvan der Velde, MElving, DWArends-Smit, REBuiter, JRvan der itte-van Aerle, IJansma, KKooistra, LLohof-Venema, SKruijer, MRDijkstra, Gvan der erf-Elling, MAKats-de Boer, VRinsema, AMHaarlemmer-Lutjeboer, Mvan der Vegt, ABerends-Pors, SMHPonstein, AJKlaassen, GNieuwint, AMVeninga-Jansen, MDries-Jansen, VArends, FJStellingwerf-Goinga, NEOvermars, NGvan Asma, HBeverdam, KPloumen, MJACTijhuis, MVisser Duiven, AHFormer, MSmans-Kaal, MALVorsterman van Oijen-Linthorst, CMJHovels-Kamp, NNVorsteveld, LRVermeulen, NAlkemade-van Veghel, ASteentjes, LJCornelisse-Theunissen, HGMStrijbosch, JSniekers, SOerlemans-van Oijen, JMAHoefnagels, HMJSniekers, CJDABiemans, SBomert-Wendt, Yvan Gaal, HGMSmulders, AHCWAdams, WKappen, JMVermeltfoort-Jansen, AMZegger, MGCVrielink, CSlotman, HMClaessens, NJHManders-de Groot, AWMvan Beuzekom-van der Vorst, CTPGSwinkels-Nijssen, MWCvan Oeveren, Pvan Leeuwen-Nellestijn, JPFBleijenberg, MValenteyn-Hidden, JJFvan Rutten-de Groot, MGvan den van der Heijden, MNieuwenhuizenBoorsma, PGBroodman, NElling, MEBokkers-Engelen, EHilhorst-Droppers, GHMein, HJCGielen, M
Source
Annals of Surgery. Jul 01, 2022 276(1):38-45
Subject
Language
English
ISSN
0003-4932
Abstract
OBJECTIVE:: To investigate the effects of PFR after LAR compared to usual care without PFR. SUMMARY OF BACKGROUND DATA:: Functional complaints, including fecal incontinence, often occur after LAR for rectal cancer. Controversy exists about the effectiveness of PFR in improving such postoperative functional outcomes. METHODS:: This was a multicenter, randomized controlled trial involving 17 Dutch centers. Patients after LAR for rectal cancer were randomly assigned (1:1) to usual care or PFR and stratified by sex and administration of neoadjuvant therapy. Selection was not based on severity of complaints at baseline. Baseline measurements were taken 3 months after surgery without temporary stoma construction or 6 weeks after stoma closure. The primary outcome measure was the change in Wexner incontinence scores 3 months after randomization. Secondary outcomes were fecal incontinence-related quality of life, colorectal-specific quality of life, and the LARS scores. RESULTS:: Between October 2017 and March 2020, 128 patients were enrolled and 106 randomly assigned (PFR n = 51, control n = 55); 95 patients (PFR n = 44, control n = 51) were assessable for final analysis. PFR did not lead to larger changes in Wexner incontinence scores in nonselected patients after LAR compared to usual care [PFR: –2.3, 95% confidence interval (CI) –3.3 to –1.4, control: –1.3, 95% CI –2.2 to –0.4, P = 0.13]. However, PFR was associated with less urgency at follow-up (odds ratio 0.22, 95% CI 0.06–0.86). Patients without near-complete incontinence reported larger Wexner score improvements after PFR (PFR: –2.1, 95% CI –3.1 to –1.1, control: –0.7, 95% CI –1.6 to 0.2, P = 0.045). For patients with at least moderate incontinence PFR resulted in relevant improvements in all fecal incontinence-related quality of life domains, while the control group deteriorated. These improvements were even larger when patients with near-complete incontinence were excluded. No serious adverse PFR-related events occurred. CONCLUSION:: No benefit was found of PFR in all patients but several subgroups were identified that did benefit from PFR, such as patients with urgency or with at least moderate incontinence and no near-complete incontinence. A selective referral policy (65%–85% of all patients) is suggested to improve postoperative functional outcomes for patients after LAR for rectal cancer. TRIAL REGISTRATION:: Netherlands Trial Registration, NTR5469, registered on 3 September 2015.